Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LEAP 2 Chronic EFS

NCT: NCT07287423 · ACTIVE_NOT_RECRUITING

NCT IDNCT07287423
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-13
Completion2028-12

Brief Summary

Prospective, single-arm, non-randomized, unblinded, chronic feasibility study designed to evaluate the safety and performance of the AVEIR™ Conduction System Pacing (CSP) Leadless Pacemaker system.

Frequently Asked Questions

What is LEAP 2 Chronic EFS?

LEAP 2 Chronic EFS is a clinical trial registered under NCT07287423. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07287423?

The current status of NCT07287423 (LEAP 2 Chronic EFS) is: ACTIVE_NOT_RECRUITING.

When did LEAP 2 Chronic EFS start?

LEAP 2 Chronic EFS started on 2025-12-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.